Showing all 3 results
Afatinib Tablets
FreeProduct Composition & Strength
We supply this product in multiple strengths to allow for precise dose titration based on patient tolerability.
Active Ingredient Strength Primary Clinical Function Afatinib (as Dimaleate) USP/Ph.Eur. 20 mg / 30 mg The Dose-Adjustment Unit: Used for patients requiring a lower dose due to gastrointestinal or skin toxicity. Afatinib (as Dimaleate) USP/Ph.Eur. 40 mg The Standard Therapeutic Anchor: The globally validated starting dose for first-line treatment of EGFR+ NSCLC. Excipients Proprietary Matrix Bio-Stable Coating: Engineered to protect the sensitive dimaleate salt and ensure consistent systemic absorption. Alpelisib Tablets
FreeProduct Composition & Strength
We supply this product in standardized daily dose packs, designed to achieve the 300 mg daily therapeutic target.
Active Ingredient Strength Primary Clinical Function Alpelisib USP/Ph.Eur. 50 mg / 150 mg The Combination Unit: Used together (150mg x 2) to reach the standard 300mg daily dose. Alpelisib USP/Ph.Eur. 200 mg The Dose-Reduction Unit: Used for patients requiring a lower dose due to side effects (Hyperglycemia/Rash). Excipients Proprietary Matrix Bio-Stable Coating: Engineered to protect the sensitive API and ensure consistent systemic absorption. Thioguanine Tablets
FreeProduct Composition & Strength
We supply this product in the globally standardized 40 mg strength, optimized for adult and pediatric weight-based dosing.
Active Ingredient Strength Primary Clinical Function Thioguanine USP/Ph.Eur. 40 mg The DNA Saboteur: Mimics guanine to stop the replication of leukemic cells. Excipients Pharmaceutical Grade Stability Matrix: Engineered to protect the sensitive API from environmental degradation.
